Thomas Meier, PhD
Founder, Chairman of the Board of Directors, Member of the Audit & Compliance Committee
Read more
About
SANTHERA
Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company committed to developing and commercializing innovative medicines to meet the needs of patients living with rare and other diseases with high unmet medical needs.
Our focus
We are focusing on the development of treatments for neuromuscular diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD).
We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.
Meet our Board of Directors
Philipp Gutzwiller
Board Member and Chairman of the Audit & Compliance Committee
Read more
Bradley C. Meyer
Board Member and Chairman of the Nomination & Compensation Committee
Read more
Dr. Melanie Rolli
Board Member and Member of the Nomination & Compensation Committee
Read more
Dr. Srishti Gupta
Board Member
Read moreMeet our Executive Committee
Orlando Oliveira
Chief Executive Officer
Read more
Catherine Isted
Chief Financial Officer
Read more
Shabir Hasham, MD
Chief Medical Officer
Read more
Oliver P. Kronenberg, PhD
Chief Legal Officer & Corporate Secretary
Read more
Marc Schrader
Chief Technology Officer
Read more
Marc Clausse
Chief Commercial Officer
Read more
